William E Achanzar1, Mukta M Webber, Michael P Waalkes. 1. Inorganic Carcinogenesis Section, National Cancer Institute at National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
Abstract
BACKGROUND: Cadmium is a suspected prostatic carcinogen, although the underlying mechanisms are unclear. To investigate these mechanisms, we performed molecular comparisons between the cadmium-transformed prostate epithelial cell line CTPE and the nontumorigenic parental line RWPE-1. METHODS: Gene expression patterns were compared by using cDNA arrays, RNase protection assays, and Western blots. Apoptosis was analyzed by using flow cytometry to quantify apoptotic nuclei and an enzyme-linked immunosorbent assay method to measure DNA fragmentation. Caspase-3 activity was measured colorimetrically. RESULTS: Among the genes down-regulated in CTPE cells were those encoding several members of the caspase family of apoptotic proteases as well as the apoptotic regulator Bax. Ribonuclease protection assays confirmed global down-regulation of caspase gene expression in CTPE. Decreased Bax expression in CTPE was confirmed by Western blots, which also revealed increased expression of anti-apoptotic Bcl-2. Consistent with these changes, CTPE cells exhibited increased resistance to apoptosis induced by cadmium, cisplatin, and etoposide. CTPE cells also exhibited lower caspase-3 activity vs. RWPE-1 after etoposide treatment. CONCLUSIONS: CTPE cells exhibited altered expression of important apoptotic regulators as well as resistance to several apoptotic stimuli. We hypothesize that acquired apoptotic resistance may be a key aspect of cadmium-induced malignant transformation of prostate epithelial cells and that this may contribute to both tumor initiation and the acquisition of aggressive characteristics subsequent to tumor formation. Copyright 2002 Wiley-Liss, Inc.
BACKGROUND:Cadmium is a suspected prostatic carcinogen, although the underlying mechanisms are unclear. To investigate these mechanisms, we performed molecular comparisons between the cadmium-transformed prostate epithelial cell line CTPE and the nontumorigenic parental line RWPE-1. METHODS: Gene expression patterns were compared by using cDNA arrays, RNase protection assays, and Western blots. Apoptosis was analyzed by using flow cytometry to quantify apoptotic nuclei and an enzyme-linked immunosorbent assay method to measure DNA fragmentation. Caspase-3 activity was measured colorimetrically. RESULTS: Among the genes down-regulated in CTPE cells were those encoding several members of the caspase family of apoptotic proteases as well as the apoptotic regulator Bax. Ribonuclease protection assays confirmed global down-regulation of caspase gene expression in CTPE. Decreased Bax expression in CTPE was confirmed by Western blots, which also revealed increased expression of anti-apoptotic Bcl-2. Consistent with these changes, CTPE cells exhibited increased resistance to apoptosis induced by cadmium, cisplatin, and etoposide. CTPE cells also exhibited lower caspase-3 activity vs. RWPE-1 after etoposide treatment. CONCLUSIONS:CTPE cells exhibited altered expression of important apoptotic regulators as well as resistance to several apoptotic stimuli. We hypothesize that acquired apoptotic resistance may be a key aspect of cadmium-induced malignant transformation of prostate epithelial cells and that this may contribute to both tumor initiation and the acquisition of aggressive characteristics subsequent to tumor formation. Copyright 2002 Wiley-Liss, Inc.
Authors: Venkatesh Kolluru; Deeksha Pal; A M Sashi Papu John; Murali K Ankem; Jonathan H Freedman; Chendil Damodaran Journal: Cancer Lett Date: 2017-08-24 Impact factor: 8.679
Authors: Fatma Trabelsi; Rim Khlifi; Didier Goux; Marilyne Guillamin; Amel Hamza-Chaffai; François Sichel Journal: Environ Sci Pollut Res Int Date: 2016-05-06 Impact factor: 4.223
Authors: Jaya P Gaddipati; N V Rajeshkumar; Jason C Grove; Susan V M Maharaj; Jose A Centeno; Radha K Maheshwari; Wayne B Jonas Journal: Nonlinearity Biol Toxicol Med Date: 2003-04
Authors: Pierpaolo Aimola; Marco Carmignani; Anna Rita Volpe; Altomare Di Benedetto; Luigi Claudio; Michael P Waalkes; Adrie van Bokhoven; Erik J Tokar; Pier Paolo Claudio Journal: PLoS One Date: 2012-03-20 Impact factor: 3.240
Authors: Wei Qu; Hengning Ke; Jingbo Pi; Daniel Broderick; John E French; Mukta M Webber; Michael P Waalkes Journal: Environ Health Perspect Date: 2007-07 Impact factor: 9.031